CSWYF 0.95 China Shineway Pharmaceutical Group Limited
| Range: | 0.9253-1.08 | Vol Avg: | 3 | Last Div: | 0.07 | Changes: | -0.08 |
| Beta: | 0.84 | Cap: | 0.76B | Currency: | USD | Exchange: | PNK |
| Sector: | Healthcare | IPO: | Tue Feb 18 2020 | Empoloyees: | 3232 | ||
| CUSIP: | CIK: | ISIN: | KYG2110P1000 | Country: | CN | ||
| CEO: | Mr. Zhenjiang Li | Website: | https://www.shineway.com | ||||
China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People's Republic of China and Hong Kong. The company offers modern Chinese medicines in the form of soft capsules, granules, and injections, as well as TCM Formula Granules in various therapeutic areas, including cardio-cerebrovascular, anti-viral, orthopedics, pediatrics, gynecology, and gastroenterology. It also trades in agricultural products. The company was incorporated in 2004 and is headquartered in Shijiazhuang, the People's Republic of China. China Shineway Pharmaceutical Group Limited is a subsidiary of Forway Investment Limited.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow